Ozge Petek Erpolat

Ozge Petek Erpolat

Auto-generated profile, based on publicly available information

Ozge Petek Erpolat

Department of Radiation Oncology, Faculty of Medicine Gazi University Ankara Türkiye

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2020 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
KÖKadirhan Özdemir
Kadirhan Özdemir
IKIlke Keser
Ilke Keser
MDMehmet Düzlü
Mehmet Düzlü
OEOzge P. Erpolat
Ozge P. Erpolat
USUluc Saranli
Uluc Saranli
HTHakan Tutar
Hakan Tutar

1 December 2020 in World Neurosurgery
Verified
Journal Article
Closed access
OEOzge Petek Erpolat
Ozge Petek Erpolat
VDVolkan Niyazi Demircan
Volkan Niyazi Demircan
GSGulistan Sanem Sarıbas
Gulistan Sanem Sarıbas
PKPelin Kuzucu
Pelin Kuzucu
ESErtugrul Senturk
Ertugrul Senturk
GKGokhan Kurt
Gokhan Kurt

3 September 2025 in Biomolecules and Biomedicine
Verified
Journal Article
Open access
PDF file
AUAybala Nur Ucgul
Aybala Nur Ucgul
ATAhmet Oguz Tugcu
Ahmet Oguz Tugcu
OEOzge Petek Erpolat
Ozge Petek Erpolat
Neoadjuvant stereotactic radiosurgery (SRS) has emerged as a promising strategy for managing brain metastases, offering several advantages over traditional postoperative approaches. By delivering targeted radiation prior to surgical resection, neoadjuvant SRS aims to enhance local tumor control, reduce the risk of leptomeningeal dissemination, and optimize treatment efficiency. Recent findings suggest that neoadjuvant SRS provides comparable, if not superior, local control compared to postoperative SRS, while exhibiting lower rates of radiation necrosis and leptomeningeal disease. However, uncertainties persist regarding optimal dosing regimens, treatment timing, and patient selection criteria, as factors such as tumor size, volume, and histology may significantly influence clinical outcomes. Additionally, while neoadjuvant SRS addresses challenges related to target delineation and delays associated with postoperative treatment, its long-term efficacy and integration with systemic therapies require further investigation. This review consolidates evidence from recent retrospective and prospective studies, focusing on key outcomes such as local control rates, radiation toxicity profiles, and overall survival.

13 September 2026 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Open access
PDF file
BEBurak Erturk
Burak Erturk
MDMehmet Düzlü
Mehmet Düzlü
ÖEÖzge P. Erpolat
Özge P. Erpolat
IKİlKe Keser
İlKe Keser
Objective: This study investigated the efficacy of a prophylactic, home‐based exercise program administered concomitantly with radiotherapy in patients with head and neck cancer to preserve swallowing function, postural alignment, and cervical range of motion, while assessing lymphedema safety. Study Design: Randomized controlled trial. Setting: Outpatient clinics of an academic university hospital. Methods: Twenty‐four patients undergoing radiotherapy for head and neck cancer were allocated to an exercise group (n = 12; receiving a swallowing, posture, range of motion, and strengthening protocol) or a control group (n = 12; receiving standard care). Baseline and postradiotherapy outcomes were assessed using the Swallowing Quality of Life questionnaire, photogrammetric posture analysis, digital goniometry for cervical mobility, and circumference measurements for lymphedema. Results: Swallowing Quality of Life was maintained in the exercise group but deteriorated significantly in controls ( P < .001). The exercise group significantly preserved neck lateral tilt compared to controls ( P < .001). Furthermore, the intervention group demonstrated significant preservation of cervical flexion, extension, rotation, and lateral flexion ( P < .05). Facial edema metrics increased slightly in both groups with no significant inter‐group differences, confirming intervention safety ( P > .05). High adherence rates were reported. Conclusion: A prophylactic, home‐based exercise program is a safe and effective strategy to mitigate functional decline in patients undergoing radiotherapy. The intervention preserves swallowing, posture, and cervical mobility without exacerbating lymphedema, supporting early prehabilitation in oncological care. Trial Registration: ClinicalTrials.gov Identifier: NCT07376213.

11 September 2026 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
ESErtugrul Senturk
Ertugrul Senturk
PEPetek Erpolat
Petek Erpolat
SKSerra Kamer
Serra Kamer
BYBirsen Yücel
Birsen Yücel
BBBüşra Şahin Barış
Büşra Şahin Barış
ESEla Delikgöz Soykut
Ela Delikgöz Soykut

1 November 2023 in Nuclear Medicine Seminars
Verified
Journal Article
Closed access
ESErtugrul Senturk
Ertugrul Senturk
PEPetek Erpolat
Petek Erpolat